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Bioinformatics helping to mitigate the impact of COVID-19 – Editorial
The coronavirus disease 2019 (COVID-19) pandemic caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) became known to the world at the end of 2019 [1]. The
severity of the pandemic and its worldwide spread provoked an
unprecedented effort of the scientific community and a lot of
new research was conducted, especially by the medicine, biology,
public health, bioinformatics and computer science researchers,
that led to the rapid development of several novel vaccines [2].
At the biological level, SARS-CoV-2 and COVID-19 research
involves several themes, including high-throughput technolo-
gies such as Next-Generation Sequencing for detecting the
genome of SARS-CoV-2, databases storing SARS-CoV-2 genomes
and variants, bioinformatics software tools and databases for
analyzing and storing host–virus interactions [3].
At the medical level and in particular when considering the
search for therapeutic strategies, the identification of COVID-19
biomarkers, the discovery of therapeutic targets for drugs and
the bioinformatics approaches for drug repurposing, i.e. the use
of already available drugs for the COVID-19 disease, are main
research themes.
At the epidemiological and public-health level, main research
themes regard: the systematic collection and sharing of data
about the spread of the infection, such as the number of cases,
hospitalized, ICU and deceased patients, that may be helpful to
manage the pandemic [4]; the biological tests for testing, and
the computational methods for tracing and tracking infected
people; the exploitation of the vast clinical data stored into the
Electronic Health Records of COVID-19 patients [5]; the analysis
of the impact of lockdown measures in various contexts, e.g. at
socioeconomic level, that may benefit from sentiment analysis
methods; and finally measures to help quarantined people, such
as local healthcare service, robotics and virtual assistants.
Finally, those unprecedented research efforts yield an over-
whelming volume of scientific publications that require new
methods and tools to improve learning from SARS-CoV-2 and
COVID-19 literature, such as novel text mining and natural lan-
guage processing techniques to distill relevant information [6].
This Special Issue aims to collect relevant scientific con-
tributions on methods and applications of bioinformatics and
informatics in themes related to COVID-19 and SARS-CoV-2. In
particular, the special issue is organized in two main strands:
one on Bioinformatics helping to mitigate the impact of Covid-19 and
another one on Informatics helping to mitigate the impact of Covid-19.
Here, we present the first-strand Bioinformatics helping to
mitigate the impact of Covid-19 that comprises more than 60
manuscripts, each dealing with one of the following central
key issues, as detailed below.
Bioinformatics tools and resources
for SARS-CoV-2 and COVID-19 research
Next-generation sequencing is the central technology for detect-
ing genomes of SARS-CoV-2 that provides the basic data about
the virus. Bioinformatics pipelines, biological and host–virus
interaction databases, are key tools for computing such data and
advancing knowledge on SARS-CoV-2.
In Next-generation sequencing of SARS-CoV-2 genomes: challenges,
applications and opportunities, Chiara, D’Erchia, Gissi, Manzari,
Parisi, Resta, Zambelli, Picardi, Pavesi, Horner and Pesole discuss
next-generation sequencing (NGS), a fundamental technology
and method for tracing origins and understanding the evolution
of infectious agents, and in particular to reconstruct the genomic
sequence of SARS-CoV-2. Authors briefly introduce available
platforms and approaches for the sequencing of SARS-CoV-2
genomes and outline current databases for SARS-CoV-2 genomic
data. As a result, they provide some useful guidelines for the
sharing and deposition of SARS-CoV-2 data and metadata, sug-
gesting the use of efficient and standardized approaches for the
production, handling and integration of SARS-CoV-2 sequencing
data.
In Bioinformatics resources for SARS-CoV-2 discovery and surveil-
lance, Hu, J. Li, Zhou, C. Li, Holmes and Shi discuss the role of next-
generation sequencing and available bioinformatics pipelines
for the worldwide genomic surveillance of SARS-CoV-2, focusing
on the tracking of COVID-19 spread and the analysis of evo-
lution and patterns of SARS-CoV-2 variation on a global scale.
The authors review the main bioinformatics resources available
for the discovery and surveillance of SARS-CoV-2 and discuss
their advantages and disadvantages, highlighting areas needing
urgent technical improvements.
In Computational strategies to combat COVID-19: useful tools
to accelerate SARS-CoV-2 and coronavirus research, Franziska Huf-
sky et al. present bioinformatics tools that have been explicitly
developed for SARS-CoV-2 with the aim to provide key tools
for the detection, understanding and treatment of COVID-19.
The reviewed tools include detection of SARS-CoV-2, analysis
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of sequencing data, tracking and containment of the COVID-19
pandemic, study of coronavirus evolution, discovery of potential
drug targets and related therapeutic strategies. All analyzed
tools are available online and free to use and for each tool the
authors describe a use case and discuss the contribution to the
SARS-CoV-2 research.
In A review on viral data sources and search systems for per-
spective mitigation of COVID-19, Bernasconi, Canakoglu, Masseroli,
Pinoli and Ceri discuss the data integration activities needed
for accessing and searching SARS-CoV-2 genome sequences and
metadata stored in main viral sequences databases. The authors
review some host-pathogen integrated datasets and underline
possible integrative surveillance mechanisms, e.g. based on the
time-space distribution of common virus variants. They observe
that while organizations already managing virus databases are
offering novel specific SARS-CoV-2 data and services, novel spe-
cific approaches and resources to face COVID-19 are appearing,
providing better accessibility of viral sequence data, integration
with clinical data and with the genotype of the human host.
The role of pathway enrichment analysis (PEA) in finding
possible targets present in biological pathways of host cells
that are targeted by SARS-CoV-2 is discussed in Comprehensive
pathway enrichment analysis workflows: COVID-19 case study. To
guide bioinformaticians in the choice of the many available
PEA methods and software tools, Agapito, Pastrello and Jurisica
highlight how to choose the most suitable PEA methods based
on the type of SARS-CoV-2/COVID-19 data to analyze.
In Web tools to fight pandemics: the COVID-19 experience, Mer-
catelli, Holding and Giorgi focus on the state of the art of COVID-
19 online resources and review the most popular web tools for
the analysis of COVID-19 data, focusing on the epidemiology,
genomics, interactomics and pharmacology fields.
COVID-19 biomarkers, drug targets
and bioinformatics approaches
for drug repurposing
The identification of COVID-19 biomarkers, the discovery of
therapeutic targets for drugs and the bioinformatics approaches
for drug repurposing are key research topics to address for facing
the COVID-19 disease. The research in these fields is mainly
driven by the SARS-CoV-2 proteins structure, protein dynamics
produced by computer simulations, variants and mutations of
the virus.
In A review of COVID-19 biomarkers and drug targets: resources
and tools, Caruso, Scala, Cerulo and Ceccarelli present a review
of tools and resources to identify biomarkers and drug tar-
gets in COVID-19, through the automatic analysis of a consol-
idated corpus of 27 570 papers. Using latent Dirichlet analysis,
authors extracted topics associated with computational meth-
ods for biomarker identification and drug repurposing, which
include machine learning and artificial intelligence for disease
characterization, vaccine development and therapeutic target
identification.
In Bioinformatics resources facilitate understanding and harnessing
clinical research of SARS-CoV-2, Ahsan, Liu, Feng, Zhou, Ma, Bai
and Chen review some bioinformatics resources, the status of
drug development and various resources for enabling research
toward effective treatment of COVID-19, including phylogenetic
characteristics, genomic conservation and interaction data. The
authors review several SARS-CoV-2-related tools and databases,
focusing on bioinformatics approaches for target prioritization
and drug repurposing. They present a web-portal named Over-
COVID that provides a detailed description of SARS-CoV-2 basics
and shares a collection of bioinformatics resources and informa-
tion that may contribute to better understanding of SARS-CoV-2
and to therapeutic advances.
In A review on drug repurposing applicable to COVID-19, Dotolo,
Marabotti, Facchiano and Tagliaferri present a review of different
drug repurposing strategies useful to face COVID-19 pandemic,
i.e. strategies for discovering new applications of existing drugs
to COVID-19, that may reduce costs and provide shorter time
application. Authors categorize computational drug repurpos-
ing approaches into network, structure and artificial intelli-
gence approaches. Network-based approaches, further catego-
rized into clustering and propagation approaches, allow the
identification of proteins that are functionally associated with
COVID-19, evidencing novel drug–disease or drug–target rela-
tionships useful for new therapies. Structure-based approaches
study how chemical compounds can interact with the macro
molecular targets, finding new possible applications for existing
drugs. Finally, artificial intelligence approaches are evaluated
less relevant at the moment, due to the scarcity of data to learn
models.
In The impact of structural bioinformatics tools and resources
on SARS-CoV-2 research and therapeutic strategies, Waman, Sen,
Varadi, Daina, Wodak, Zoete, Velankar and Orengo review
recent structural bioinformatics tools and discuss the impact of
structure-based studies on SARS-CoV-2 research, with focus on
the differences between SARS-CoV-2 and SARS-CoV, the SARS-
CoV-2 residues involved in receptor–antibody recognition, the
variants in host proteins that affect susceptibility to infection,
and the computational analyses enabling structure-based drug
and vaccine development.
In SARS-CoV-2 3D database: understanding the coronavirus
proteome and evaluating possible drug targets, Alsulami, Thomas,
Jamasb, Beaudoin, Moghul, Bannerman, Copoiu, Vedithi, Torres
and Blundell propose a new database containing 3D models
of the SARS-CoV-2 proteome, including models of protomers
and oligomers, protein-ligand docking, interactions of SARS-
CoV-2 proteins with human proteins, impacts of mutations and
experimental structures. The resulting SARS-CoV-2 3D database
provides information for drug discovery, useful to evaluate
targets and design new possible therapeutics.
Knowledge extraction from SARS-CoV-2
and COVID-19 literature
The unprecedented rate of SARS-CoV-2 and COVID-19 publica-
tions strongly accelerated the development of text mining and
natural language processing techniques to analyze scientific
literature.
In Text mining approaches for dealing with the rapidly expand-
ing literature on COVID-19, Wang and Lo tackle the problem of
extracting recent knowledge from the overwhelming COVID-19
literature using text mining applications and discuss the cor-
pora, models and systems that have been introduced for COVID-
19. They analyzed 39 systems that support search, discovery,
visualization and summarization of the COVID-19 literature, and
categorized them through qualitative description, performance
assessment and user interface. The authors note that some
systems, in addition to standard functions such as search and
discovery, provide new functions such as summary of multiple
documents or connections between scientific articles and clini-
cal trials.
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In How do we share data in COVID-19 research? A systematic
review of COVID-19 datasets in PubMed Central Articles, Zuo, Chen,
Ohno-Machado and Xu review more than 100 datasets about
COVID-19 that were reported into several scientific articles avail-
able from PubMed Central. Starting from 12 324 COVID-19 full-
text articles published until 31 May 2020, the authors extracted
the links to 128 datasets that were manually reviewed using
10 variables. Although the analysis was performed in an initial
stage of the pandemic, the authors found 128 unique dataset
links. The largest portion (53.9%) are epidemiological datasets
and most datasets (84.4%) were available for immediate down-
load. The study found that GitHub was the most used repository
and evidenced a great heterogeneity in the way the datasets are
mentioned, shared, and updated.
Key infrastructures, technologies
and applications for managing
the COVID-19 pandemic
In addition to bioinformatics research, COVID-19 pandemic has
given an impulse to the development and adaption of several
informatics techniques, including computational methods for
tracing and tracking infected people; collaborative data infras-
tructures for COVID-19 research; sentiment analysis methods for
monitoring the impact of lockdown measures; artificial intel-
ligence methods and robotics applications to support remote
patients assistance (e.g. quarantined people).
In Health informatics and EHR to support clinical research in
the COVID-19 pandemic: an overview, Dagliati, Malovini, Tibollo
and Bellazzi discuss the role of Electronic Health Records (EHR)
that are primarily used to support day-by-day clinical activities,
to enable global scale research on COVID-19. Authors review
collaborative data infrastructures to support COVID-19 research,
including studies on effectiveness of drugs and therapeutic
strategies, and discuss the data sharing and governance issues
emerged with the COVID-19 pandemic, that may prevent a
full exploitation of EHR data, especially when considering
international collaborations. The authors underline the data
management, interoperability and governance issues, the
modelling of healthcare processes and the management of data
privacy regulations as primary aspects to boost collaborative
research.
In Robots as intelligent assistants to face COVID-19 pandemic, Sei-
dita, Lanza, Pipitone and Chella discuss the role that an emerging
technology such as robotics may have in the management and
fight against the COVID-19 pandemic. Authors analyzed scien-
tific articles and industrial initiatives underlining how robotics
was used to face the pandemic, its level of readiness, what are
the expectations from robots and what remains to do. Authors
reviewed what is offered by research groups in terms of robot
support for therapies and for prevention actions and discussed
the maturity of robotics in dealing with situations like COVID-19.
In HVIDB: a comprehensive database for human-virus protein-
protein interaction, X. Yang, Lian, Fu, Wuchty, S. Yang and Zhang
present HVIDB (Human-Virus Interaction DataBase), an anno-
tated human-virus protein–protein interaction (PPI) database
that contains experimentally verified human-virus PPIs about 35
virus families, experimentally verified 3D complex structures of
human-virus PPIs, and integrates machine learning models to
predict interactions between human host and viral proteins.
Although research on SARS-CoV-2 and COVID-19 is contin-
uously evolving, we hope this special issue will represent an
authoritative and valuable resource for researchers. The Editors
are grateful to both the Editor-in-Chief and the Publisher for
having sustained this project, for their timely help, and for
having supported them in the day-to-day needs. A special thank
is addressed to all the authors and reviewers, whose competence
and effort allowed the realization of this special issue.
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